Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain<blockquote>Adagio Therapeutics继续其狂野之旅——两项测试如何带来三位数的收益</blockquote>
New analyses suggest Adagio Therapeutics' Covid antibody could still tackle the omicron variant — and ADGI stock soared on Thursday.